Antipsychotic News and Research RSS Feed - Antipsychotic News and Research

Antipsychotics are medicines used to treat the symptoms of mental disorders such as schizophrenia, depression, bipolar disorder (sometimes called manic-depressive illness), anxiety disorders, and attention deficit-hyperactivity disorder (ADHD). Sometimes medications are used with other treatments such as psychotherapy.
Women with dementia receive less health monitoring than men, UCL research reveals

Women with dementia receive less health monitoring than men, UCL research reveals

Women with dementia have fewer visits to the GP, receive less health monitoring and take more potentially harmful medication than men with dementia, new UCL (University College London) research reveals. [More]
Scientists identify microrna that provides clues for quieting auditory hallucinations of schizophrenia

Scientists identify microrna that provides clues for quieting auditory hallucinations of schizophrenia

St. Jude Children's Research Hospital scientists have identified a small RNA (microRNA) that may be essential to restoring normal function in a brain circuit associated with the "voices" and other hallucinations of schizophrenia. [More]
Personalized medicine may offer solution for treatment of psychiatric disturbances

Personalized medicine may offer solution for treatment of psychiatric disturbances

An ever widening gap is appearing between clinical practice and the treatment prescribed in DSM-5, the standard work on schizophrenia, psychiatrist Jan Dirk Blom will assert in his inaugural lecture on 11 November. [More]
Lack of shrinkage in the hippocampus may help predict people at risk for dementia with Lewy bodies

Lack of shrinkage in the hippocampus may help predict people at risk for dementia with Lewy bodies

Dementia with Lewy bodies is a progressive disease that causes hallucinations, decline in mental abilities, rigid muscles, slow movement and tremors. With symptoms similar to Alzheimer's disease and Parkinson's disease, a correct diagnosis can be difficult. [More]
Lack of brain shrinkage may help identify people at risk for dementia with Lewy bodies

Lack of brain shrinkage may help identify people at risk for dementia with Lewy bodies

A lack of shrinkage in the area of the brain responsible for memory may be a sign that people with thinking and memory problems may go on to develop dementia with Lewy bodies rather than Alzheimer's disease, according to a new study published in the November 2, 2016, online issue of Neurology, a medical journal of the American Academy of Neurology. [More]
Folinic acid treatment could help improve language and communication skills of children with ASD

Folinic acid treatment could help improve language and communication skills of children with ASD

Prescription doses of folinic acid, which is a reduced form of a B vitamin known as folate, could help improve the language and communication skills of children with autism spectrum disorder (ASD). [More]
Researchers underscore how oxidative stress and inflammation may contribute to risk of schizophrenia

Researchers underscore how oxidative stress and inflammation may contribute to risk of schizophrenia

Schizophrenia is a devastating mental illness consisting of delusions, hallucinations or disorganized thoughts, afflicting about 1% of the population with onset typically in late adolescence. [More]
Researchers identify process in the brains of mice that may explain repetitive actions in Rett patients

Researchers identify process in the brains of mice that may explain repetitive actions in Rett patients

Three-year-old Naomi slaps her forehead a few times, bites her fingers and toddles across the doctor's office in her white and pink pajamas before turning her head into a door with a dull thud. [More]
Mood stabilizers may decrease negative symptoms in psychiatric patients with specific genotype

Mood stabilizers may decrease negative symptoms in psychiatric patients with specific genotype

A drug prescribed to many patients with schizophrenia or bipolar disorder may decrease negative symptoms for people with a certain variant of the COMT gene, suggests a new study from researchers at Columbia University Medical Center. [More]
Antipsychotic use linked to higher pneumonia risk in patients with Alzheimer's disease

Antipsychotic use linked to higher pneumonia risk in patients with Alzheimer's disease

Antipsychotic medications are associated with an increased risk of pneumonia in persons with Alzheimer's disease (AD), according to new research from the University of Eastern Finland. [More]
Study explores relationship between moderate-vigorous exercise and psychotic symptoms

Study explores relationship between moderate-vigorous exercise and psychotic symptoms

Physical activity can help reduce cardiovascular disease and premature mortality in people with psychological problems. [More]
Diabetes drug linked to decreased weight gain in children with autism spectrum disorder

Diabetes drug linked to decreased weight gain in children with autism spectrum disorder

The diabetes medication metformin hydrochloride was associated with decreased weight gain in a small clinical trial of children and adolescents with autism spectrum disorder who were taking atypical antipsychotics to treat symptoms of irritability and agitation, according to an article published online by JAMA Psychiatry. [More]

Low adherence to antipsychotic medication linked to long-term homelessness

SFU health sciences researcher Stefanie Rezansoff has published a new study on the treatment of serious mental illnesses among people who are homeless. This is the first study to investigate adherence to antipsychotic medication in this population. [More]
New CBIT therapy can help lessen frequency of tics

New CBIT therapy can help lessen frequency of tics

When Dr. Laura Duda goes into an elementary school classroom, she can usually spot one or two children who have a tic - a rapid, involuntary movement or sound such as sniffing, blinking their eyes or scrunching their faces. [More]
Study highlights effectiveness of atypical antipsychotic drug in treating children with TD

Study highlights effectiveness of atypical antipsychotic drug in treating children with TD

A meta-analysis of clinical trials evaluating the effectiveness of aripiprazole for the treatment of Tourette's disorder (TD) in children and adolescents showed a significantly greater overall improvement in total tics and tic severity from pretreatment to post-treatment for the aripiprazole compared to the placebo group. [More]
Antipsychotic drug could help reduce nausea and vomiting caused by chemotherapy

Antipsychotic drug could help reduce nausea and vomiting caused by chemotherapy

A drug that blocks neurotransmitters could reduce nausea and vomiting caused by chemotherapy, research co-authored by a Sanford Health physician and published in the New England Journal of Medicine finds. [More]
Study explores rate of antipsychotic polypharmacy among patients discharged from psychiatric hospitals

Study explores rate of antipsychotic polypharmacy among patients discharged from psychiatric hospitals

In recent years, measures have been introduced to reduce the rate of "antipsychotic polypharmacy"—taking more than one antipsychotic drug—among patients with schizophrenia and other serious mental illnesses. [More]
Study compares aripiprazole and quetiapine for treatment of schizophrenia

Study compares aripiprazole and quetiapine for treatment of schizophrenia

Schizophrenia is a common cause of incapacity and is ranked as the third-most-disabling illness subsequent to dementia and quadriplegia. [More]
Scientists discover key cellular mechanism behind side-effects of antipsychotics

Scientists discover key cellular mechanism behind side-effects of antipsychotics

Since their development in the 1950s, antipsychotic drugs have been widely used to treat psychoses and neuropsychiatric disorders like schizophrenia. A debilitating side-effect of these drugs called parkinsonism limits their efficacy. [More]
Children in foster care still face quality challenges in antipsychotic medication use

Children in foster care still face quality challenges in antipsychotic medication use

Significant quality challenges persist in antipsychotic medication use for children in foster care and other Medicaid-insured children, according to a new Rutgers University-New Brunswick study published in Health Affairs. [More]
Advertisement
Advertisement